Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

NCT01773278 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01773278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2008
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cone-rod dystrophy, hearing loss, smith-lemli-opitz syndrome